机构:
BEILINSON MED CTR,IL-49100 PETAH TIQWA,ISRAELBEILINSON MED CTR,IL-49100 PETAH TIQWA,ISRAEL
BARKAI, G
[1
]
CHAKI, R
论文数: 0引用数: 0
h-index: 0
机构:
BEILINSON MED CTR,IL-49100 PETAH TIQWA,ISRAELBEILINSON MED CTR,IL-49100 PETAH TIQWA,ISRAEL
CHAKI, R
[1
]
SOCHAT, M
论文数: 0引用数: 0
h-index: 0
机构:
BEILINSON MED CTR,IL-49100 PETAH TIQWA,ISRAELBEILINSON MED CTR,IL-49100 PETAH TIQWA,ISRAEL
SOCHAT, M
[1
]
GOLDMAN, B
论文数: 0引用数: 0
h-index: 0
机构:
BEILINSON MED CTR,IL-49100 PETAH TIQWA,ISRAELBEILINSON MED CTR,IL-49100 PETAH TIQWA,ISRAEL
GOLDMAN, B
[1
]
机构:
[1] BEILINSON MED CTR,IL-49100 PETAH TIQWA,ISRAEL
来源:
AMERICAN JOURNAL OF MEDICAL GENETICS
|
1991年
/
41卷
/
01期
关键词:
TRISOMY-18;
MATERNAL SERUM;
LOW BETA-HCG;
D O I:
10.1002/ajmg.1320410115
中图分类号:
Q3 [遗传学];
学科分类号:
071007 ;
090102 ;
摘要:
Estimation of maternal serum-beta-hCG is used in conjunction with alpha-fetoprotein (AFP) and estriol (E3) for estimating the risk of Down syndrome (DS) affected fetuses. However, low hCG levels have not been regarded as having clinical significance. We report on 2 patients with trisomy 18 fetuses in whom antenatal screening showed extremely low hCG levels (0.05 and 0.15 MOM). Low hCG levels might indicate increased risk for trisomy 18 despite low estimated risk for DS.
引用
收藏
页码:52 / 53
页数:2
相关论文
共 2 条
[1]
ARAB H, 1988, American Journal of Human Genetics, V43, pA225